BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 30322937)

  • 1. Hypertrophic cardiomyopathy R403Q mutation in rabbit β-myosin reduces contractile function at the molecular and myofibrillar levels.
    Lowey S; Bretton V; Joel PB; Trybus KM; Gulick J; Robbins J; Kalganov A; Cornachione AS; Rassier DE
    Proc Natl Acad Sci U S A; 2018 Oct; 115(44):11238-11243. PubMed ID: 30322937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional effects of the hypertrophic cardiomyopathy R403Q mutation are different in an alpha- or beta-myosin heavy chain backbone.
    Lowey S; Lesko LM; Rovner AS; Hodges AR; White SL; Low RB; Rincon M; Gulick J; Robbins J
    J Biol Chem; 2008 Jul; 283(29):20579-89. PubMed ID: 18480046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Point mutations in human beta cardiac myosin heavy chain have differential effects on sarcomeric structure and assembly: an ATP binding site change disrupts both thick and thin filaments, whereas hypertrophic cardiomyopathy mutations display normal assembly.
    Becker KD; Gottshall KR; Hickey R; Perriard JC; Chien KR
    J Cell Biol; 1997 Apr; 137(1):131-40. PubMed ID: 9105042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential cross-bridge kinetics of FHC myosin mutations R403Q and R453C in heterozygous mouse myocardium.
    Palmer BM; Fishbaugher DE; Schmitt JP; Wang Y; Alpert NR; Seidman CE; Seidman JG; VanBuren P; Maughan DW
    Am J Physiol Heart Circ Physiol; 2004 Jul; 287(1):H91-9. PubMed ID: 15001446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Faster cross-bridge detachment and increased tension cost in human hypertrophic cardiomyopathy with the R403Q MYH7 mutation.
    Witjas-Paalberends ER; Ferrara C; Scellini B; Piroddi N; Montag J; Tesi C; Stienen GJ; Michels M; Ho CY; Kraft T; Poggesi C; van der Velden J
    J Physiol; 2014 Aug; 592(15):3257-72. PubMed ID: 24928957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myofilament mechanical performance is enhanced by R403Q myosin in mouse myocardium independent of sex.
    Palmer BM; Wang Y; Teekakirikul P; Hinson JT; Fatkin D; Strouse S; Vanburen P; Seidman CE; Seidman JG; Maughan DW
    Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1939-47. PubMed ID: 18281382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-molecule mechanics of R403Q cardiac myosin isolated from the mouse model of familial hypertrophic cardiomyopathy.
    Tyska MJ; Hayes E; Giewat M; Seidman CE; Seidman JG; Warshaw DM
    Circ Res; 2000 Apr; 86(7):737-44. PubMed ID: 10764406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic mouse α- and β-cardiac myosins containing the R403Q mutation show isoform-dependent transient kinetic differences.
    Lowey S; Bretton V; Gulick J; Robbins J; Trybus KM
    J Biol Chem; 2013 May; 288(21):14780-7. PubMed ID: 23580644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered crossbridge kinetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy.
    Blanchard E; Seidman C; Seidman JG; LeWinter M; Maughan D
    Circ Res; 1999 Mar; 84(4):475-83. PubMed ID: 10066683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The familial hypertrophic cardiomyopathy-associated myosin mutation R403Q accelerates tension generation and relaxation of human cardiac myofibrils.
    Belus A; Piroddi N; Scellini B; Tesi C; D'Amati G; Girolami F; Yacoub M; Cecchi F; Olivotto I; Poggesi C
    J Physiol; 2008 Aug; 586(15):3639-44. PubMed ID: 18565996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. R403Q and L908V mutant beta-cardiac myosin from patients with familial hypertrophic cardiomyopathy exhibit enhanced mechanical performance at the single molecule level.
    Palmiter KA; Tyska MJ; Haeberle JR; Alpert NR; Fananapazir L; Warshaw DM
    J Muscle Res Cell Motil; 2000; 21(7):609-20. PubMed ID: 11227787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial hypertrophic cardiomyopathy: functional effects of myosin mutation R723G in cardiomyocytes.
    Kraft T; Witjas-Paalberends ER; Boontje NM; Tripathi S; Brandis A; Montag J; Hodgkinson JL; Francino A; Navarro-Lopez F; Brenner B; Stienen GJ; van der Velden J
    J Mol Cell Cardiol; 2013 Apr; 57():13-22. PubMed ID: 23318932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hypertrophic cardiomyopathy mutations R403Q and R663H increase the number of myosin heads available to interact with actin.
    Sarkar SS; Trivedi DV; Morck MM; Adhikari AS; Pasha SN; Ruppel KM; Spudich JA
    Sci Adv; 2020 Apr; 6(14):eaax0069. PubMed ID: 32284968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Missense mutations in the beta-myosin heavy-chain gene cause central core disease in hypertrophic cardiomyopathy.
    Fananapazir L; Dalakas MC; Cyran F; Cohn G; Epstein ND
    Proc Natl Acad Sci U S A; 1993 May; 90(9):3993-7. PubMed ID: 8483915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional consequences of mutations in the smooth muscle myosin heavy chain at sites implicated in familial hypertrophic cardiomyopathy.
    Yamashita H; Tyska MJ; Warshaw DM; Lowey S; Trybus KM
    J Biol Chem; 2000 Sep; 275(36):28045-52. PubMed ID: 10882745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertrophic cardiomyopathy β-cardiac myosin mutation (P710R) leads to hypercontractility by disrupting super relaxed state.
    Vander Roest AS; Liu C; Morck MM; Kooiker KB; Jung G; Song D; Dawood A; Jhingran A; Pardon G; Ranjbarvaziri S; Fajardo G; Zhao M; Campbell KS; Pruitt BL; Spudich JA; Ruppel KM; Bernstein D
    Proc Natl Acad Sci U S A; 2021 Jun; 118(24):. PubMed ID: 34117120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cardiac myosin heavy chain Arg-403-->Gln mutation that causes hypertrophic cardiomyopathy does not affect the actin- or ATP-binding capacities of two size-limited recombinant myosin heavy chain fragments.
    Eldin P; Le Cunff M; Mornet D; Leger JJ
    Biochem J; 1995 Mar; 306 ( Pt 2)(Pt 2):345-51. PubMed ID: 7887887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Restrictive Cardiomyopathy Mutation in an Invariant Proline at the Myosin Head/Rod Junction Enhances Head Flexibility and Function, Yielding Muscle Defects in Drosophila.
    Achal M; Trujillo AS; Melkani GC; Farman GP; Ocorr K; Viswanathan MC; Kaushik G; Newhard CS; Glasheen BM; Melkani A; Suggs JA; Moore JR; Swank DM; Bodmer R; Cammarato A; Bernstein SI
    J Mol Biol; 2016 Jun; 428(11):2446-2461. PubMed ID: 27107639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of expression of cardiac phenotypes over a 4-year period in the beta-myosin heavy chain-Q403 transgenic rabbit model of human hypertrophic cardiomyopathy.
    Nagueh SF; Chen S; Patel R; Tsybouleva N; Lutucuta S; Kopelen HA; Zoghbi WA; Quiñones MA; Roberts R; Marian AJ
    J Mol Cell Cardiol; 2004 May; 36(5):663-73. PubMed ID: 15135661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rat cardiac troponin T mutation (F72L)-mediated impact on thin filament cooperativity is divergently modulated by α- and β-myosin heavy chain isoforms.
    Chandra V; Gollapudi SK; Chandra M
    Am J Physiol Heart Circ Physiol; 2015 Oct; 309(8):H1260-70. PubMed ID: 26342069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.